J Mora

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. ncbi Spontaneous remission of congenital acute nonlymphoblastic leukemia with normal karyotype in twins
    J Mora
    Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Med Pediatr Oncol 35:110-3. 2000
  2. ncbi Survival analysis of clinical, pathologic, and genetic features in neuroblastoma presenting as locoregional disease
    J Mora
    Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 91:435-42. 2001
  3. ncbi Molecular genetics of neuroblastoma and the implications for clinical management: a review of the MSKCC experience
    J Mora
    Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Oncologist 6:263-8. 2001
  4. ncbi Genetic heterogeneity and clonal evolution in neuroblastoma
    J Mora
    Departments of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Br J Cancer 85:182-9. 2001
  5. ncbi Loss of heterozygosity at 19q13.3 is associated with locally aggressive neuroblastoma
    J Mora
    Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    Clin Cancer Res 7:1358-61. 2001
  6. ncbi Neuroblastic and Schwannian stromal cells of neuroblastoma are derived from a tumoral progenitor cell
    J Mora
    Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    Cancer Res 61:6892-8. 2001
  7. ncbi Comprehensive analysis of the 9p21 region in neuroblastoma suggests a role for genes mapping to 9p21-23 in the biology of favourable stage 4 tumours
    J Mora
    Department of Molecular Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Br J Cancer 91:1112-8. 2004
  8. ncbi N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age
    N K Cheung
    Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Med Pediatr Oncol 36:227-30. 2001

Collaborators

Detail Information

Publications8

  1. ncbi Spontaneous remission of congenital acute nonlymphoblastic leukemia with normal karyotype in twins
    J Mora
    Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Med Pediatr Oncol 35:110-3. 2000
    ..Spontaneous remission of congenital leukemia has been reported and related to the presence of an extra chromosome 21...
  2. ncbi Survival analysis of clinical, pathologic, and genetic features in neuroblastoma presenting as locoregional disease
    J Mora
    Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 91:435-42. 2001
    ..Although these patients generally have an excellent survival with minimal therapy, some do experience recurrence with lethal consequences...
  3. ncbi Molecular genetics of neuroblastoma and the implications for clinical management: a review of the MSKCC experience
    J Mora
    Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Oncologist 6:263-8. 2001
    ....
  4. ncbi Genetic heterogeneity and clonal evolution in neuroblastoma
    J Mora
    Departments of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Br J Cancer 85:182-9. 2001
    ..These findings suggest that NB exhibits a high degree of clonal heterogeneity and clonal evolution occurs during the course of therapy and clinical progression...
  5. ncbi Loss of heterozygosity at 19q13.3 is associated with locally aggressive neuroblastoma
    J Mora
    Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    Clin Cancer Res 7:1358-61. 2001
    ..In multivariant analysis, 19q13 LOH was associated with overall survival in local-regional International Neuroblastoma Staging System stages 1, 2, and 3 patients and was specifically present in tumors at the site of recurrence...
  6. ncbi Neuroblastic and Schwannian stromal cells of neuroblastoma are derived from a tumoral progenitor cell
    J Mora
    Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    Cancer Res 61:6892-8. 2001
    ....
  7. ncbi Comprehensive analysis of the 9p21 region in neuroblastoma suggests a role for genes mapping to 9p21-23 in the biology of favourable stage 4 tumours
    J Mora
    Department of Molecular Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Br J Cancer 91:1112-8. 2004
    ..The only well-characterised transcript among them was nuclear factor I-B3. Our results suggest a role for genes located telomeric of 9p21 in good risk NB...
  8. ncbi N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age
    N K Cheung
    Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Med Pediatr Oncol 36:227-30. 2001
    ....